Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
122.76
+0.76 (0.62%)
Aug 13, 2025, 2:59 PM - Market open

Landsea Homes Statistics

Total Valuation

Insmed has a market cap or net worth of $25.95 billion. The enterprise value is $24.58 billion.

Market Cap25.95B
Enterprise Value 24.58B

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

Insmed has 211.37 million shares outstanding. The number of shares has increased by 22.38% in one year.

Current Share Class 211.37M
Shares Outstanding 211.37M
Shares Change (YoY) +22.38%
Shares Change (QoQ) +4.67%
Owned by Insiders (%) 0.74%
Owned by Institutions (%) 87.96%
Float 194.42M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 55.41
Forward PS 39.14
PB Ratio 20.61
P/TBV Ratio 23.73
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 61.73
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.68, with a Debt / Equity ratio of 0.59.

Current Ratio 6.68
Quick Ratio 6.13
Debt / Equity 0.59
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -10.49

Financial Efficiency

Return on equity (ROE) is -160.54% and return on invested capital (ROIC) is -34.07%.

Return on Equity (ROE) -160.54%
Return on Assets (ROA) -27.03%
Return on Invested Capital (ROIC) -34.07%
Return on Capital Employed (ROCE) -42.79%
Revenue Per Employee $313,222
Profits Per Employee -$813,801
Employee Count1,271
Asset Turnover 0.19
Inventory Turnover 0.98

Taxes

In the past 12 months, Insmed has paid $4.44 million in taxes.

Income Tax 4.44M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +65.62% in the last 52 weeks. The beta is 0.95, so Insmed's price volatility has been similar to the market average.

Beta (5Y) 0.95
52-Week Price Change +65.62%
50-Day Moving Average 100.39
200-Day Moving Average 79.74
Relative Strength Index (RSI) 81.93
Average Volume (20 Days) 2,734,167

Short Selling Information

The latest short interest is 9.54 million, so 4.51% of the outstanding shares have been sold short.

Short Interest 9.54M
Short Previous Month 9.69M
Short % of Shares Out 4.51%
Short % of Float 4.91%
Short Ratio (days to cover) 3.67

Income Statement

In the last 12 months, Insmed had revenue of $398.11 million and -$1.03 billion in losses. Loss per share was -$5.72.

Revenue398.11M
Gross Profit 301.43M
Operating Income -927.68M
Pretax Income -799.73M
Net Income -1.03B
EBITDA -917.46M
EBIT -927.68M
Loss Per Share -$5.72
Full Income Statement

Balance Sheet

The company has $1.86 billion in cash and $739.04 million in debt, giving a net cash position of $1.12 billion or $5.29 per share.

Cash & Cash Equivalents 1.86B
Total Debt 739.04M
Net Cash 1.12B
Net Cash Per Share $5.29
Equity (Book Value) 1.25B
Book Value Per Share 5.92
Working Capital 1.77B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$844.55 million and capital expenditures -$24.02 million, giving a free cash flow of -$868.57 million.

Operating Cash Flow -844.55M
Capital Expenditures -24.02M
Free Cash Flow -868.57M
FCF Per Share -$4.11
Full Cash Flow Statement

Margins

Gross margin is 75.72%, with operating and profit margins of -233.02% and -259.82%.

Gross Margin 75.72%
Operating Margin -233.02%
Pretax Margin -258.70%
Profit Margin -259.82%
EBITDA Margin -230.46%
EBIT Margin -233.02%
FCF Margin n/a

Dividends & Yields

Insmed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.38%
Shareholder Yield -22.38%
Earnings Yield -4.03%
FCF Yield -3.38%
Dividend Details

Analyst Forecast

The average price target for Insmed is $132.07, which is 7.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target $132.07
Price Target Difference 7.58%
Analyst Consensus Strong Buy
Analyst Count 17
Revenue Growth Forecast (5Y) 61.84%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on March 3, 2011. It was a reverse split with a ratio of 1:10.

Last Split Date Mar 3, 2011
Split Type Reverse
Split Ratio 1:10

Scores

Insmed has an Altman Z-Score of 3.44 and a Piotroski F-Score of 3.

Altman Z-Score 3.44
Piotroski F-Score 3